Larry Douglas Altstiel - 07 Jul 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Medical Officer
Signature
/s/ Jason L. Langford, Attorney-in-Fact for Larry Douglas Altstiel
Issuer symbol
PMN
Transactions as of
07 Jul 2022
Net transactions value
$0
Form type
3
Filing time
07 Jul 2022, 19:29:49 UTC
Next filing
30 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) 07 Jul 2022 Common Shares 2,500 $8.40 Direct F1, F2
holding PMN Option (right to buy) 07 Jul 2022 Common Shares 30,833 $7.20 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that 833 options vest immediately upon grant, with the balance vesting equally over 24 months. The option was granted on February 10, 2022.
F3 The option agreement provides that the options become exercisable in 48 equal monthly installments beginning one month after the grant. The option was granted on April 14, 2022.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney